SC
INMB icon

Sepio Capital’s INmune Bio INMB Stock Holding History

Sepio Capital’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,200
Closed -$147K – 352
2022
Q4 		$147K Sell
23,200
-1,200
-5% -$8.52K 0.01% 331
2022
Q3 		$151K Buy
24,400
+2,400
+11% +$21.1K 0.02% 313
2022
Q2 		$194K Buy
+22,000
New +$164K 0.02% 323

Other funds holding INMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sepio Capital's INMB Position: Q1 2023 in Review

Sepio Capital sold out of INmune Bio (INMB) in Q1 2023, closing a stake of 23,200 shares — an estimated $147K sold.

Sepio Capital first reported a position in INMB in Q2 2022 and held it in 3 quarters. The position peaked at $194K in Q2 2022. 35 funds tracked by Wall St. Rank hold INMB as of Q1 2023.

  • Sepio Capital reported no remaining INmune Bio position as of Q1 2023 after selling out during the quarter.
  • Sepio Capital sold 23,200 INmune Bio shares in Q1 2023, an estimated $147K.
  • Sepio Capital first reported a position in INmune Bio in Q2 2022 and held it in 3 quarters.
  • Sepio Capital's INmune Bio position peaked at $194K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held INmune Bio as of Q1 2023.

Based on Sepio Capital's 13F filing for Q1 2023, filed 10 May 2023.